Open Government: Use of Genetic Information in Documenting and Evaluating Disability; Extension of Comment Period, 78462-78463 [2013-30805]
Download as PDF
<![CDATA[
78462
Federal Register / Vol. 78, No. 248 / Thursday, December 26, 2013 / Notices
December and January. The Exchange
also believes that its proposal is
reasonable because it is not changing
the thresholds to become eligible or the
dollar value associated with the rebates
and, moreover, by continuing to exclude
odd lots from the calculation of average
daily TCV, Members will be more likely
to meet the minimum or higher tier
thresholds for December and January,
which will provide additional incentive
to Members to increase their
participation on the Exchange in order
to meet the next tier. In addition, the
Exchange believes that the proposed
changes to fees are equitably allocated
among Exchange constituents as the
methodology for calculating ADV and
TCV will apply equally to all Members.
Volume-based tiers such as the
liquidity adding tiers maintained by the
Exchange have been widely adopted in
the equities markets, and are equitable
and not unfairly discriminatory because
they are open to all members on an
equal basis and provide rebates that are
reasonably related to the value to an
exchange’s market quality associated
with higher levels of market activity,
such as higher levels of liquidity
provision and introduction of higher
volumes of orders into the price and
volume discovery process. Accordingly,
the Exchange believes that the proposal
is equitably allocated and not unfairly
discriminatory because it is consistent
with the overall goals of enhancing
market quality.
B. Self-Regulatory Organization’s
Statement on Burden on Competition
emcdonald on DSK67QTVN1PROD with NOTICES
The Exchange does not believe that
the proposed rule change will impose
any burden on competition not
necessary or appropriate in furtherance
of the purposes of the Act. The
proposed changes will help the
Exchange to continue to incentivize
higher levels of liquidity at a tighter
spread while providing more stable and
predictable costs to its Members. As
stated above, the Exchange notes that it
operates in a highly competitive market
in which market participants can
readily direct order flow to competing
venues if they deem fee structures to be
unreasonable or excessive.
C. Self-Regulatory Organization’s
Statement on Comments on the
Proposed Rule Change Received From
Members, Participants, or Others
The Exchange has neither solicited
nor received written comments on the
proposed rule change.
VerDate Mar<15>2010
18:06 Dec 24, 2013
Jkt 232001
III. Date of Effectiveness of the
Proposed Rule Change and Timing for
Commission Action
The foregoing rule change has become
effective pursuant to Section 19(b)(3)(A)
of the Act 11 and paragraph (f) of Rule
19b–4 thereunder.12 At any time within
60 days of the filing of the proposed rule
change, the Commission summarily may
temporarily suspend such rule change if
it appears to the Commission that such
action is necessary or appropriate in the
public interest, for the protection of
investors, or otherwise in furtherance of
the purposes of the Act.
IV. Solicitation of Comments
Interested persons are invited to
submit written data, views and
arguments concerning the foregoing,
including whether the proposed rule
change is consistent with the Act.
Comments may be submitted by any of
the following methods:
Electronic Comments
• Use the Commission’s Internet
comment form (https://www.sec.gov/
rules/sro.shtml); or
• Send an email to rule-comments@
sec.gov. Please include File Number SR–
BATS–2013–063 on the subject line.
Paper Comments
• Send paper comments in triplicate
to Elizabeth M. Murphy, Secretary,
Securities and Exchange Commission,
100 F Street NE., Washington, DC
20549–1090.
All submissions should refer to File
Number SR–BATS–2013–063. This file
number should be included on the
subject line if email is used. To help the
Commission process and review your
comments more efficiently, please use
only one method. The Commission will
post all comments on the Commission’s
Internet Web site (https://www.sec.gov/
rules/sro.shtml). Copies of the
submission, all subsequent
amendments, all written statements
with respect to the proposed rule
change that are filed with the
Commission, and all written
communications relating to the
proposed rule change between the
Commission and any person, other than
those that may be withheld from the
public in accordance with the
provisions of 5 U.S.C. 552, will be
available for Web site viewing and
printing in the Commission’s Public
Reference Room, 100 F Street NE.,
Washington, DC 20549, on official
business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of such
11 15
12 17
PO 00000
U.S.C. 78s(b)(3)(A).
CFR 240.19b–4(f).
Frm 00138
Fmt 4703
filing also will be available for
inspection and copying at the principal
office of the Exchange. All comments
received will be posted without change;
the Commission does not edit personal
identifying information from
submissions. You should submit only
information that you wish to make
available publicly. All submissions
should refer to File Number SR–BATS–
2013–063 and should be submitted on
or before January 16, 2014.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.13
Kevin M. O’Neill,
Deputy Secretary.
[FR Doc. 2013–30761 Filed 12–24–13; 8:45 am]
BILLING CODE 8011–01–P
SOCIAL SECURITY ADMINISTRATION
[Docket No. SSA–2013–0054]
Open Government: Use of Genetic
Information in Documenting and
Evaluating Disability; Extension of
Comment Period
Social Security Administration.
Notice of extension of comment
AGENCY:
ACTION:
period.
On November 26, 2013, we
announced in the Federal Register that
we were soliciting ideas and comments
about the use of genetic information in
the disability determination process via
an online forum. We stated that the
forum would be open until December
26, 2013. We are extending that
deadline until January 16, 2014.
DATES: The forum will be open for your
ideas and comments until January 16,
2014.
FOR FURTHER INFORMATION CONTACT:
Cheryl A. Williams, Office of Medical
Listings Improvement, Social Security
Administration, 6401 Security
Boulevard, Baltimore, Maryland 21235–
6401, (410) 965–1020. For information
on eligibility or filing for benefits, call
our national toll-free number, 1–800–
772–1213, or TTY 1–800–325–0778, or
visit our Internet site, Social Security
Online, at https://
www.socialsecurity.gov.
SUPPLEMENTARY INFORMATION:
On November 26, 2013, we
announced in the Federal Register that
we were soliciting ideas and comments
about the use of genetic information in
the disability determination process via
an online forum that would be open
until December 26, 2013.1 We have
SUMMARY:
13 17
1 78
Sfmt 4703
E:\FR\FM\26DEN1.SGM
CFR 200.30–3(a)(12).
FR 70617.
26DEN1
Federal Register / Vol. 78, No. 248 / Thursday, December 26, 2013 / Notices
decided to extend that deadline until
January 16, 2014.
We would like the public’s ideas and
comments regarding how we should use
genetic information within the disability
decision process. Under our current,
long-standing policy, we do not
purchase genetic testing to evaluate
disability. However, we do consider all
evidence in the record, including
genetic testing and other genetic
medical evidence, when we make a
determination or decision of whether
you are disabled.2
We solicited the public’s ideas and
comments on the use of genetic
information in order to obtain
innovative ideas that we could use to
improve the disability determination
process. Your comments are important
to us and we encourage you to share
your ideas on any and all related issues.
Some of the specific issues we would
like information on include:
• What role should genetic specialists
have in providing medical evidence?;
• Should we use direct-to-consumer
genetic test results, and if so, how
should we use those results?;
• How useful is genetic information
in determining prognosis and
progression of an impairment?;
• What role should genetic
information have in the continuing
disability review process?;
CFR 404.1512–404.1513, 404.1520, 416.912–
416.913, and 416.920.
emcdonald on DSK67QTVN1PROD with NOTICES
2 20
VerDate Mar<15>2010
18:06 Dec 24, 2013
Jkt 232001
• Can we make determinations
regarding known genetic conditions in
the absence of genetic test results, and
if so, how should we do so?;
• What privacy safeguards should we
apply when we obtain and use genetic
information?; and
• Are there any related issues that
may inform our future policies?
How To Participate
The forum is open to all members of
the public. To submit your ideas and
comments, please go to https://www.ssadisabilityideas.ideascale.com and go to
the Campaign entitled ‘‘Genetic
Information.’’ You must register at the
site before you are able to submit your
ideas and comments. Although we will
consider all of the ideas and comments
we receive, we will not respond to
them. Since we will moderate the ideas
and comments we receive during
regular business hours, your ideas and
comments may not be viewable
immediately. In most cases, your ideas
and comments should be viewable
within two business days.
Include only information that you
wish to make publicly available. Please
do not include any personal
information, such as Social Security
numbers or medical information.
Arthur R. Spencer,
Associate Commissioner, Office of Disability
Programs.
[FR Doc. 2013–30805 Filed 12–24–13; 8:45 am]
BILLING CODE 4191–02–P
PO 00000
Frm 00139
Fmt 4703
Sfmt 4703
78463
DEPARTMENT OF STATE
[Public Notice 8574]
Summary of the Certification Related
to the Khmer Rouge Tribunal
On June 26, 2013, Deputy Secretary
William Burns signed a required
certification for the Khmer Rouge
Tribunal, per section 7044(c) of the
Department of State, Foreign
Operations, and Related Programs Act,
2012 (Division I, Pub. L. 112–74) as
carried forward by the Full-Year
Continuing Appropriation Act, 2013
(Div. F, Pub. L. 113–6), that the United
Nations and the Royal Government of
Cambodia are taking credible steps to
address allegations of corruption and
mismanagement within the
Extraordinary Chambers in the Courts of
Cambodia (also known as the ‘‘Khmer
Rouge Tribunal’’).
The Certification and related
Memorandum of Justification are to be
provided to the appropriate committees
of the Congress and published in the
Federal Register.
I am signing the below to verify and
affirm Deputy Secretary Burns signature
and meet the requirements for
publication of these documents in the
Federal Register.
Dated: December 10, 2013.
Ed Shin,
Special Assistant for Deputy Secretary Burns.
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 78, Number 248 (Thursday, December 26, 2013)]
[Notices]
[Pages 78462-78463]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-30805]
=======================================================================
-----------------------------------------------------------------------
SOCIAL SECURITY ADMINISTRATION
[Docket No. SSA-2013-0054]
Open Government: Use of Genetic Information in Documenting and
Evaluating Disability; Extension of Comment Period
AGENCY: Social Security Administration.
ACTION: Notice of extension of comment period.
-----------------------------------------------------------------------
SUMMARY: On November 26, 2013, we announced in the Federal Register
that we were soliciting ideas and comments about the use of genetic
information in the disability determination process via an online
forum. We stated that the forum would be open until December 26, 2013.
We are extending that deadline until January 16, 2014.
DATES: The forum will be open for your ideas and comments until January
16, 2014.
FOR FURTHER INFORMATION CONTACT: Cheryl A. Williams, Office of Medical
Listings Improvement, Social Security Administration, 6401 Security
Boulevard, Baltimore, Maryland 21235-6401, (410) 965-1020. For
information on eligibility or filing for benefits, call our national
toll-free number, 1-800-772-1213, or TTY 1-800-325-0778, or visit our
Internet site, Social Security Online, at https://www.socialsecurity.gov.
SUPPLEMENTARY INFORMATION:
On November 26, 2013, we announced in the Federal Register that we
were soliciting ideas and comments about the use of genetic information
in the disability determination process via an online forum that would
be open until December 26, 2013.\1\ We have
[[Page 78463]]
decided to extend that deadline until January 16, 2014.
---------------------------------------------------------------------------
\1\ 78 FR 70617.
---------------------------------------------------------------------------
We would like the public's ideas and comments regarding how we
should use genetic information within the disability decision process.
Under our current, long-standing policy, we do not purchase genetic
testing to evaluate disability. However, we do consider all evidence in
the record, including genetic testing and other genetic medical
evidence, when we make a determination or decision of whether you are
disabled.\2\
---------------------------------------------------------------------------
\2\ 20 CFR 404.1512-404.1513, 404.1520, 416.912-416.913, and
416.920.
---------------------------------------------------------------------------
We solicited the public's ideas and comments on the use of genetic
information in order to obtain innovative ideas that we could use to
improve the disability determination process. Your comments are
important to us and we encourage you to share your ideas on any and all
related issues. Some of the specific issues we would like information
on include:
What role should genetic specialists have in providing
medical evidence?;
Should we use direct-to-consumer genetic test results, and
if so, how should we use those results?;
How useful is genetic information in determining prognosis
and progression of an impairment?;
What role should genetic information have in the
continuing disability review process?;
Can we make determinations regarding known genetic
conditions in the absence of genetic test results, and if so, how
should we do so?;
What privacy safeguards should we apply when we obtain and
use genetic information?; and
Are there any related issues that may inform our future
policies?
How To Participate
The forum is open to all members of the public. To submit your
ideas and comments, please go to https://www.ssa-disabilityideas.ideascale.com and go to the Campaign entitled ``Genetic
Information.'' You must register at the site before you are able to
submit your ideas and comments. Although we will consider all of the
ideas and comments we receive, we will not respond to them. Since we
will moderate the ideas and comments we receive during regular business
hours, your ideas and comments may not be viewable immediately. In most
cases, your ideas and comments should be viewable within two business
days.
Include only information that you wish to make publicly available.
Please do not include any personal information, such as Social Security
numbers or medical information.
Arthur R. Spencer,
Associate Commissioner, Office of Disability Programs.
[FR Doc. 2013-30805 Filed 12-24-13; 8:45 am]
BILLING CODE 4191-02-P
